UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory

Completed

Conditions: Diverticulitis

First Posted Date: 2016-05-18

Last Posted Date: 2022-12-05

Lead Sponsor: University of Washington

Target Recruit Count: 418

Registration Number: NCT02776787

Locations: 🇺🇸
Northwest Hospital and Medical Center, Seattle, Washington, United States
🇺🇸
NYU Langone Health, Brooklyn, New York, United States
🇺🇸
UCLA Ronald Reagan, Los Angeles, California, United States

and more 6 locations

Topical Antibiotic Treatment for Spine Surgical Site Infection

Completed

Conditions: Surgical Wound Infection

First Posted Date: 2016-05-18

Last Posted Date: 2019-08-13

Lead Sponsor: University of Washington

Target Recruit Count: 91

Registration Number: NCT02776774

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging

Phase 2

Completed

Conditions: Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
Stage IIIA Lung Non-Small Cell Cancer AJCC v7
Stage IIIB Lung Non-Small Cell Cancer AJCC v7

Interventions: Procedure: Computed Tomography
Radiation: Fludeoxyglucose F-18
Other: Laboratory Biomarker Analysis
Procedure: Positron Emission Tomography
Radiation: Radiation Therapy
Procedure: Single Photon Emission Computed Tomography
Radiation: Technetium Tc-99m Albumin Aggregated
Radiation: Technetium Tc-99m Sulfur Colloid

First Posted Date: 2016-05-16

Last Posted Date: 2024-08-14

Lead Sponsor: University of Washington

Target Recruit Count: 51

Registration Number: NCT02773238

Locations: 🇺🇸
SCCA Proton Therapy Center, Seattle, Washington, United States
🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Pembrolizumab in Treating Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia

Phase 2

Terminated

Conditions: B Acute Lymphoblastic Leukemia
Minimal Residual Disease
T Acute Lymphoblastic Leukemia
Recurrent Acute Lymphoblastic Leukemia

Interventions: Other: Laboratory Biomarker Analysis
Biological: Pembrolizumab

First Posted Date: 2016-05-11

Last Posted Date: 2020-08-20

Lead Sponsor: University of Washington

Target Recruit Count: 12

Registration Number: NCT02767934

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

The Added Value of a Mobile Application of Community Case Management on Pediatric Referral Rates in Malawi

Not Applicable

Completed

Conditions: Infectious Diseases

Interventions: Other: Standard care
Other: Supporting LIFE electronic Community Case Management

First Posted Date: 2016-05-05

Last Posted Date: 2024-01-23

Lead Sponsor: University of Washington

Target Recruit Count: 6995

Registration Number: NCT02763345

Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms

Phase 2

Completed

Conditions: High Grade Malignant Neoplasm
Previously Treated Myelodysplastic Syndrome
Recurrent Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
Myelodysplastic Syndrome With Excess Blasts-2
Myeloid Neoplasm
Blasts 10 Percent or More of Bone Marrow Nucleated Cells
Chronic Myelomonocytic Leukemia-2
Myelodysplastic Syndrome

Interventions: Drug: Cladribine
Drug: Cyclosporine
Drug: Cytarabine
Biological: Filgrastim
Drug: Fludarabine Phosphate
Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
Other: Laboratory Biomarker Analysis
Drug: Melphalan
Drug: Mitoxantrone Hydrochloride
Drug: Mycophenolate Mofetil
Other: Questionnaire Administration
Drug: Sirolimus
Radiation: Total-Body Irradiation
Drug: Melphalan Hydrochloride

First Posted Date: 2016-04-29

Last Posted Date: 2021-11-08

Lead Sponsor: University of Washington

Target Recruit Count: 30

Registration Number: NCT02756572

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Anticipatory Counseling on LNG-IUS Continuation, Utilization and Satisfaction

Not Applicable

Conditions: Uterine Cramping
Vaginal Bleeding

Interventions: Other: Anticipatory Counseling
Other: Cancer Screening Guidelines

First Posted Date: 2016-04-26

Last Posted Date: 2019-04-18

Lead Sponsor: University of Washington

Target Recruit Count: 178

Registration Number: NCT02752282

Locations: 🇺🇸
University of California Los Angeles Medical Center, Los Angeles, California, United States
🇺🇸
University of Washington Medical Centers, Seattle, Washington, United States
🇺🇸
Stroger Hospital of Cook County, Chicago, Illinois, United States

Testing for the Presence of Authorship Bias in Peer Review

Not Applicable

Completed

Conditions: Peer Review

Interventions: Other: Unblinded manuscript
Other: Blinded manuscript

First Posted Date: 2016-04-15

Last Posted Date: 2016-04-15

Lead Sponsor: University of Washington

Target Recruit Count: 119

Registration Number: NCT02739737

Study to Promote Innovation in Rural Integrated Telepsychiatry

Not Applicable

Completed

Conditions: Bipolar Disorder
Posttraumatic Stress Disorder

Interventions: Behavioral: Telepsychiatry Collaborative Care
Behavioral: Telepsychiatry Enhanced Referral

First Posted Date: 2016-04-14

Last Posted Date: 2020-12-24

Lead Sponsor: University of Washington

Target Recruit Count: 1004

Registration Number: NCT02738944

Locations: 🇺🇸
Lee County Cooperative Clinic, Marianna, Arkansas, United States
🇺🇸
Upper Great Lakes Family Health Center, Gwinn, Michigan, United States
🇺🇸
Health Delivery, Inc, Saginaw, Michigan, United States

and more 10 locations

Tethered Capsule Endoscope in Screening Patients With Barrett Esophagus

Not Applicable

Completed

Conditions: Barrett Esophagus

Interventions: Other: Survey Administration
Device: Tethered Capsule Endoscope

First Posted Date: 2016-04-06

Last Posted Date: 2019-01-23

Lead Sponsor: University of Washington

Target Recruit Count: 1

Registration Number: NCT02729948

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy